Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/05/2012WO2011133867A3 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
04/05/2012WO2011133841A3 Intravenous omega-3 fatty acid compositions & method of use
04/05/2012WO2011116152A3 Delivery of agents using interfering nanoparticles
04/05/2012WO2011112732A3 Methods of treating vascular inflammatory disorders
04/05/2012WO2011107281A3 Antimicrobial oil-in-water emulsion containing quaternary ammonium compounds
04/05/2012WO2011103382A3 Compositions and methods for inducing angiogenesis
04/05/2012WO2011084638A3 Mesalamine suppository
04/05/2012WO2011068404A3 Administration of n-(3-ethynylphenylamino)-6,7-bis(2- methoxyethoxy)-4-quinazolinamine mesylate salt by inhalation
04/05/2012WO2011020933A8 Liposomes covered with the extracellular domain of the apo2l/trail protein
04/05/2012US20120083536 Antimicrobial adhesive system
04/05/2012US20120083535 Adhesive mixture for transdermal delivery of highly plasticizing drugs
04/05/2012US20120083534 Ophthalmic and contact lens solution
04/05/2012US20120083530 Thermally Stable Oil-in-Water Emulsions Containing an Oil That Contains Polyunsaturated Fatty Acids
04/05/2012US20120083515 Bioadhesive gel based on hydroxyethylcellulose
04/05/2012US20120083480 Controlled release delivery system for nasal applications
04/05/2012US20120083446 Novel albumin-free factor viii formulations
04/05/2012US20120083412 Composition and Method for Delivery of Substances in a Dry Mode Having a Surface Layer
04/05/2012US20120082733 Methods for processing microspheres, microspheres processed thereby, and uses thereof
04/05/2012US20120082732 Medicine for treatment of a carcinoma
04/05/2012US20120082731 Method For Removing Residual Organic Solvent From Microparticles
04/05/2012US20120082730 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
04/05/2012US20120082729 Quick dissolve compositions and tablets based thereon
04/05/2012US20120082728 Multifunctional stealth nanoparticules for biomedical use
04/05/2012US20120082727 Use of magnesium stearate in dry powder formulations for inhalation
04/05/2012US20120082726 Surface-treated modafinil particles
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
04/05/2012US20120082724 Dry mouldable drug formulation
04/05/2012US20120082723 Easily administrable solid preparation
04/05/2012US20120082722 Methods and compositions for oral delivery of fts
04/05/2012US20120082721 Enteric coating
04/05/2012US20120082720 Compositions For Treating Chronic Viral Infections
04/05/2012US20120082719 Compositions For Treating Chronic Viral Infections
04/05/2012US20120082718 Morphine Formulations
04/05/2012US20120082717 Complex, multilayer using the same, and device coated with the multilayer
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082715 Stabilized products, processes and devices for preparing the same
04/05/2012US20120082714 Transdermal therapeutic system with crystallization-inhibiting protective film (release liner)
04/05/2012US20120082713 Photochrome- or near ir dye-coupled polymeric matrices for medical articles
04/05/2012US20120082710 Methods and compositions for treating acne
04/05/2012US20120082709 Compositions and methods for delivery of materials
04/05/2012US20120082706 Medical device for drug delivery
04/05/2012US20120082705 Tetra Calcium Phosphate Based Organophosphorus Compositions and Methods
04/05/2012US20120082704 Oxygenated demineralized bone matrix for use in bone growth
04/05/2012US20120082627 Otic foam formulations
04/05/2012US20120082626 Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
04/05/2012US20120082625 Combination treatment for rosacea
04/05/2012US20120082616 Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers
04/05/2012DE102007026969B4 Verfahren zur Herstellung einer diffraktiven Gitter-Mikrostruktur auf der Oberfläche einer Tablette A process for producing a diffractive grating microstructure on the surface of a tablet
04/05/2012DE102007026957B4 Pharmazeutische Tabletten mit diffraktiver Mikrostruktur Pharmaceutical tablets with a diffractive microstructure
04/05/2012CA2849546A1 Dry processing of atazanavir
04/05/2012CA2813302A1 Emulsion method for preparing low residual solvent microparticles
04/05/2012CA2813301A1 Method for removing residual organic solvent from microparticles
04/05/2012CA2813253A1 Method of preparing a dry powder from a water bacteria extract-concentrate
04/05/2012CA2813147A1 Preparation for improving solubility of poorly soluble drug
04/05/2012CA2813096A1 Use of magnesium stearate in dry powder formulations for inhalation
04/05/2012CA2813013A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
04/05/2012CA2812901A1 Cyclosporine emulsion
04/05/2012CA2812862A1 Enteric coated, low-strength pancrelipase formulations
04/05/2012CA2812790A1 Therapeutic use of a tlr agonist and combination therapy
04/05/2012CA2812787A1 Methods for the treatment of allergic diseases
04/05/2012CA2812510A1 Pharmaceutical composition
04/05/2012CA2812505A1 Pharmaceutical composition
04/05/2012CA2812414A1 Monovalent metal cation dry powders for inhalation
04/05/2012CA2811430A1 Low molecular weight cationic lipids for oligonucleotide delivery
04/05/2012CA2811345A1 Compound composition for inhalation used for treating asthma
04/04/2012EP2436673A1 Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-beta1-42 peptide
04/04/2012EP2436395A2 An allergen dosage form
04/04/2012EP2436390A1 Topical Anesthetic Uses of Szeto-Schiller Peptides
04/04/2012EP2436386A1 Stable lyophilized preparation comprising anthracycline compound
04/04/2012EP2436384A2 Aripiprazole oral solution
04/04/2012EP2436383A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/04/2012EP2436380A1 Patch material
04/04/2012EP2436379A1 Stable tablet formulation
04/04/2012EP2436378A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
04/04/2012EP2436377A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
04/04/2012EP2436376A1 Cancer cell targeting using nanoparticles
04/04/2012EP2436375A1 Pharmaceutical compositions comprising fentanyl for intranasal delivery
04/04/2012EP2436374A1 Ovule for vaginal administration of arasertaconazole
04/04/2012EP2436273A1 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
04/04/2012EP2435095A2 Immunomodulatory agent-polymeric compounds
04/04/2012EP2435094A2 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
04/04/2012EP2435092A2 Nanocarriers possessing components with different rates of release
04/04/2012EP2435082A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
04/04/2012EP2435052A1 Solid oral dosage forms of lamivudine
04/04/2012EP2435050A2 Methods for administration and formulations for the treatment of regional adipose tissue
04/04/2012EP2435045A2 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
04/04/2012EP2435042A1 Method for preparing hollow particles, and uses thereof
04/04/2012EP2435032A1 Topical or transdermal delivery kit
04/04/2012EP2435031A1 Functional amphiphilic molecule or macromolecule formulations with multiple compartments
04/04/2012EP2435030A2 Controlled-release floating pharmaceutical compositions
04/04/2012EP2435029A1 Pharmaceutical composition comprising tamsulosin
04/04/2012EP2435028A2 Dry powder fibrin sealant
04/04/2012EP2435027A2 Reduction of flake-like aggregation in nanoparticulate active agent compositions
04/04/2012EP2435026A1 Treatment of tissue adhesion
04/04/2012EP2435025A2 Respiratory delivery of active agents
04/04/2012EP2435024A2 Compositions for respiratory delivery of active agents and associated methods and systems
04/04/2012EP2435023A2 Compositon for plumonary delivery of long-agting muscarinic antagonists and long long-acting beta 2 adrenergic receptor agonists and associated methods and systems
04/04/2012EP2435022A2 Self-microemulsifying mitotane composition
04/04/2012EP2435021A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
04/04/2012EP2435019A1 Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 2991